Evidence for a novel neuronal mechanism driving Alzheimer's disease, upstream of amyloid
This perspective offers an alternative to the amyloid hypothesis in the etiology of Alzheimer's disease (AD). We review evidence for a novel signaling mechanism based on a little‐known peptide, T14. T14 could drive neurodegeneration as an aberrantly activated process of plasticity selective to...
Main Authors: | Garcia Ratés, S, García‐Ayllón, M, Falgàs, N, Brangman, SA, Esiri, MM, Coen, CW, Greenfield, SA |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Wiley Open Access
2024
|
Similar Items
-
Target tau, not amyloid, to prevent and treat Alzheimer’s disease
by: Esiri, MM
Published: (2020) -
Antagonising a novel toxin “T14” in Alzheimer’s disease: Comparison of receptor blocker versus antibody effects in vitro
by: Sibah Hasan, et al.
Published: (2023-02-01) -
Neuronal Rubicon Represses Extracellular APP/Amyloid β Deposition in Alzheimer’s Disease
by: Sandra Espinoza, et al.
Published: (2022-06-01) -
A novel process driving Alzheimer's disease validated in a mouse model: Therapeutic potential
by: Susan A. Greenfield, et al.
Published: (2022-01-01) -
If amyloid drives Alzheimer disease, why have anti-amyloid therapies not yet slowed cognitive decline?
by: Christian Haass, et al.
Published: (2022-07-01)